CH2 board appointment for ‘major contributor’

Clifford Hallam Healthcare (CH2) has appointed Carmen Riley to its board of directors.

CH2 says Ms Riley has been a key member of its team for more than 10 years and contributed significantly to the success of the business during this time.

It adds that she has successfully led the CH2 sales team through multiple large-scale projects, including its recent launch into the retail pharmacy market.

“This appointment is in recognition of the high regard we have for Carmen’s work ethic and dedication, in addition to her skills and knowledge of the healthcare market,” CH2’s CEO David Collins said.

CH2 says it is looking forward to continuing to work with Ms Riley as it executes its  strategy of seeking to be the preferred independent wholesaler to the healthcare market.

Must Read

Improving the lives of PCOS sufferers

Polycystic ovarian syndrome (PCOS) is a common hormonal condition that affects one in 10 women of reproductive age1, and up to 13 per cent...